Loading…

Royal Philips announced a definitive agreement to acquire BioTelemetry, Inc. for $72.00 per share, implying an enterprise value of $2.8 billion, to expand patient care management solutions.
“The acquisition of BioTelemetry is a strong fit with Philips’ cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with integrated solutions.”philips.com
Summarized from public sources; check the original articles before acting on it.